The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 12220407 B1

Date of Patent:

Feb. 11, 2025

Filed:

Dec. 06, 2022

Life extension for humans and other mammals

Applicant:

Richard Postrel, Miami Beach, FL (US);

Inventor:

Richard Postrel, Miami Beach, FL (US);

Assignee:

Attorney:

Primary Examiner:

Yvonne R Abbott-Lewis

Int. Cl.

CPC ...

A61K 31/05 (2006.01); A61K 31/07 (2006.01); A61K 31/122 (2006.01); A61K 31/197 (2006.01); A61K 31/375 (2006.01); A61K 31/4188 (2006.01); A61K 31/436 (2006.01); A61K 31/4415 (2006.01); A61K 31/455 (2006.01); A61K 31/51 (2006.01); A61K 31/519 (2006.01); A61K 31/525 (2006.01); A61K 31/566 (2006.01); A61K 31/592 (2006.01); A61K 31/593 (2006.01); A61K 31/714 (2006.01); A61K 33/00 (2006.01); A61K 33/04 (2006.01); A61K 33/06 (2006.01); A61K 33/26 (2006.01); A61K 33/30 (2006.01); A61K 33/32 (2006.01); A61K 33/42 (2006.01); A61K 36/185 (2006.01); A61K 47/44 (2017.01); A61P 39/00 (2006.01);

U.S. Cl.

CPC ...

A61K 31/436 (2013.01); A61K 31/05 (2013.01); A61K 31/07 (2013.01); A61K 31/122 (2013.01); A61K 31/197 (2013.01); A61K 31/375 (2013.01); A61K 31/4188 (2013.01); A61K 31/4415 (2013.01); A61K 31/455 (2013.01); A61K 31/51 (2013.01); A61K 31/519 (2013.01); A61K 31/525 (2013.01); A61K 31/566 (2013.01); A61K 31/592 (2013.01); A61K 31/593 (2013.01); A61K 31/714 (2013.01); A61K 33/00 (2013.01); A61K 33/04 (2013.01); A61K 33/06 (2013.01); A61K 33/26 (2013.01); A61K 33/30 (2013.01); A61K 33/32 (2013.01); A61K 33/42 (2013.01); A61K 36/185 (2013.01); A61K 47/44 (2013.01); A61P 39/00 (2018.01);

Abstract

The present invention discloses a system and method for increasing the lifespan and quality of life of human beings and other mammals. This discloses methods for preparing and delivering various health and longevity compositions. The compositions of the present invention are selected and designed for the purpose of efficiently delivering health and longevity enhancing therapies through oral supplementation, misting, nasal spray, suppository, etc. An existing compound known to have capacity for life extending potential, rapamycin, is combined with a non-toxic therapeutic anabolic hormone, e.g., DHEA, and cannabidiol (CBD) to enable absorption and effect. These three compounds work together to dramatically improve both the quality of life in aging humans and other mammals as well as extending the life of humans potentially up to 120 healthy years. One preferred embodiment provides a method for continuous low dose supplementation, e.g., incorporated in or with a daily meal. This invention not only resolves the issue of anti-aging of higher life forms, without toxicity, but provides for an improved method for absorption.

Find Patent Forward Citations